Asymptomatic individuals with a positive family history for premature coronary artery disease and elevated coronary calcium scores benefit from statin treatment: A post hoc analysis from the St. Francis heart study

JACC: Cardiovascular Imaging

Volumn 5, Issue 3, 2012, Pages 252-260

  Mulders, Ties A ^a   Sivapalaratnam, Suthesh ^a   Stroes, Erik S G ^a   Kastelein, John J P ^a   Guerci, Alan D ^b   Pinto Sietsma, Sara Joan ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ST FRANCIS HOSPITAL   (United States)

Author keywords

coronary artery calcification; coronary calcium score; family history; premature coronary artery disease

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ASCORBIC ACID; ATORVASTATIN; PLACEBO;

ADULT; ARTERY SURGERY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; CORONARY CALCIUM SCORING; DRUG EFFICACY; FAMILY HISTORY; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; POST HOC ANALYSIS; PREMATURE CORONARY ARTERY DISEASE; PRIORITY JOURNAL; RELATIVE; SCORING SYSTEM; STROKE;

AGE OF ONSET; AGED; ASYMPTOMATIC DISEASES; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; NEW YORK; PATIENT SELECTION; PEDIGREE; PRIMARY PREVENTION; PROPORTIONAL HAZARDS MODELS; PYRROLES; RISK ASSESSMENT; RISK FACTORS; STROKE; TIME FACTORS; TREATMENT OUTCOME; VASCULAR CALCIFICATION;

EID: 84858325566     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2011.11.014     Document Type: Article

References (31)

1. M.B. Andresdottir, G. Sigurdsson, H. Sigvaldason, V. Gudnason Fifteen percent of myocardial infarctions and coronary revascularizations explained by family history unrelated to conventional risk factors The Reykjavik Cohort Study Eur Heart J 23 2002 1655 1663 (Pubitemid 36287776)
2. D.M. Lloyd-Jones, B.H. Nam, R.B. D'Agostino Sr. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring JAMA 291 2004 2204 2211 (Pubitemid 38608169)
3. B. Philips, J.A. de Lemos, M.J. Patel, D.K. McGuire, A. Khera Relation of family history of myocardial infarction and the presence of coronary arterial calcium in various age and risk factor groups Am J Cardiol 99 2007 825 829 (Pubitemid 46365607)
4. S. Sivapalaratnam, S.M. Boekholdt, M.D. Trip Family history of premature coronary heart disease and risk prediction in the EPIC-Norfolk prospective population study Heart 96 2010 1985 1989
5. H.D. Sesso, I.M. Lee, J.M. Gaziano, K.M. Rexrode, R.J. Glynn, J.E. Buring Maternal and paternal history of myocardial infarction and risk of cardiovascular disease in men and women Circulation 104 2001 393 398 (Pubitemid 32678267)
6. K. Nasir, E.D. Michos, J.A. Rumberger Coronary artery calcification and family history of premature coronary heart disease: sibling history is more strongly associated than parental history Circulation 110 2004 2150 2156 (Pubitemid 39372493)
7. A.M. Rissanen Familial occurrence of coronary heart disease: effect of age at diagnosis Am J Cardiol 44 1979 60 66 (Pubitemid 9216893)
8. V. Sailam, D.G. Karalis, A. Agarwal Prevalence of emerging cardiovascular risk factors in younger individuals with a family history of premature coronary heart disease and low Framingham risk score Clin Cardiol 31 2008 542 545
9. M.J. Budoff, L.J. Shaw, S.T. Liu Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients J Am Coll Cardiol 49 2007 1860 1870 (Pubitemid 46661110)
10. M.J. LaMonte, S.J. Fitzgerald, B.D. Levine Coronary artery calcium, exercise tolerance, and CHD events in asymptomatic men Atherosclerosis 189 2006 157 162 (Pubitemid 44441292)
11. Y. Arad, K.J. Goodman, M. Roth, D. Newstein, A.D. Guerci Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study J Am Coll Cardiol 46 2005 158 165 (Pubitemid 40905145)
12. L.J. Shaw, P. Raggi, E. Schisterman, D.S. Berman, T.Q. Callister Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality Radiology 228 2003 826 833 (Pubitemid 37025495)
13. J.A. Rumberger, D.B. Simons, L.A. Fitzpatrick, P.F. Sheedy, R.S. Schwartz Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area A histopathologic correlative study Circulation 92 1995 2157 2162
14. A.J. Taylor, M. Cerqueira, J.M. Hodgson ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/ SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance J Am Coll Cardiol 56 2010 1864 1894
15. P. Greenland, J.S. Alpert, G.A. Beller 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 56 2010 e50 e103
16. P. Perrone-Filardi, S. Achenbach, S. Mohlenkamp Cardiac computed tomography and myocardial perfusion scintigraphy for risk stratification in asymptomatic individuals without known cardiovascular disease: a position statement of the Working Group on Nuclear Cardiology and Cardiac CT of the European Society of Cardiology Eur Heart J 32 2011 1986 1993
17. Y. Arad, L.A. Spadaro, M. Roth, D. Newstein, A.D. Guerci Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial J Am Coll Cardiol 46 2005 166 172 (Pubitemid 40905146)
18. Y. Arad, D. Newstein, M. Roth, A.D. Guerci Rationale and design of the St. Francis Heart Study: a randomized clinical trial of atorvastatin plus antioxidants in asymptomatic persons with elevated coronary calcification Control Clin Trials 22 2001 553 572 (Pubitemid 32907439)
19. G.A. Rose The diagnosis of ischaemic heart pain and intermittent claudication in field surveys Bull World Health Organ 27 1962 645 658
20. A.S. Agatston, W.R. Janowitz, F.J. Hildner, N.R. Zusmer, M. Viamonte Jr., R. Detrano Quantification of coronary artery calcium using ultrafast computed tomography J Am Coll Cardiol 15 1990 827 832 (Pubitemid 20101575)
21. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
22. F.M. Sacks, M.A. Pfeffer, L.A. Moye Cholesterol and Recurrent Events Trial investigators The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels N Engl J Med 335 1996 1001 1009 (Pubitemid 26338729)
23. C.K. Chow, A.C. Pell, A. Walker, C. O'Dowd, A.F. Dominiczak, J.P. Pell Families of patients with premature coronary heart disease: an obvious but neglected target for primary prevention BMJ 335 2007 481 485 (Pubitemid 47401607)
24. H.S. Hecht, S.M. Harman Relation of aggressiveness of lipid-lowering treatment to changes in calcified plaque burden by electron beam tomography Am J Cardiol 92 2003 334 336 (Pubitemid 36897727)
25. H.S. Hecht, S.M. Harman Comparison of the effects of atorvastatin versus simvastatin on subclinical atherosclerosis in primary preventionas determined by electronbeam tomography Am J Cardiol 91 2003 42 45 (Pubitemid 36050768)
26. P. Raggi, M. Davidson, T.Q. Callister Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES) Circulation 112 2005 563 571 (Pubitemid 41060797)
27. A. Schmermund, S. Achenbach, T. Budde Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial Circulation 113 2006 427 437 (Pubitemid 43803205)
28. M.Y. Henein, A. Owen Statins moderate coronary stenoses but not coronary calcification: results from meta-analyses Int J Cardiol 153 2011 31 35
29. P.M. Ridker, E. Danielson, F.A. Fonseca Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial Lancet 373 2009 1175 1182
30. H.D. Sesso, J.E. Buring, W.G. Christen Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial JAMA 300 2008 2123 2133
31. K. Asplund Antioxidant vitamins in the prevention of cardiovascular disease: a systematic review J Intern Med 251 2002 372 392 (Pubitemid 34534113)